Clinical trials
Completed Phase 1 Ureteral Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2015 | 2 |
| 2018 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dr Anders Ullén | 1 |
| Eli Lilly and Company | 1 |
| H. Lee Moffitt Cancer Center and Research Institute | 1 |
| M.D. Anderson Cancer Center | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
| National Cancer Institute (NCI) | 1 |
| Rahul Aggarwal | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ureteral Neoplasms | 7 |
| Urinary Bladder Neoplasms | 6 |
| Urethral Neoplasms | 5 |
| Carcinoma, Transitional Cell | 4 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Biliary Tract Neoplasms | 1 |
| Carcinoma | 1 |
| Lung Neoplasms | 1 |
| Melanoma | 1 |
| Neoplasm Metastasis | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.